November 8, 2024 · Form 4 insider transaction
ROBERTS EIRY bought 5,140 shares of Neurocrine Biosciences, Inc. at $77.81 per share, a transaction worth $399.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock.